Emkay Global Financial Services Ltd. Share Price

Ceat’s Expansion Gamble: Cross-Selling Synergies

, India’s fourth-largest tyre maker, is leveraging its $225 million acquisition of Camso to run a consolidated dual-brand play. Ceat will position itself as a value-for-money brand, while Camso will serve premium customers in off-road, construction, and agricultural segments. Cross-selling opportunities: Managing Director Arnab Banerjee highlighted synergies from overlapping customer bases. Clients purchasing both agricultural and construction tyres can now be offered bundled solutions across Ceat and Camso, unlocking immediate revenue potential. Global expansion focus: Ceat is prioritizing North America and Europe, setting up warehouses and logistics networks to replicate Camso’s “just-in-time” service model. This move aims to strengthen relationships with global machinery companies like CNH and Kubota. Financial strain and investor concerns: Despite strategic ambitions, Ceat’s net profit plunged 96% in the June quarter due to high commodity costs and integration expenses. Shares have dropped 13% in 2026, underperforming the Nifty Auto index. Investors remain cautious about margin recovery timelines. Industry context: The acquisition comes amid Indian tyre makers seeking new growth avenues beyond domestic demand. Peers like Balkrishna Industries (BKT) and JK Tyre are diversifying or scouting acquisitions, while Ceat bets heavily on international expansion. Analyst outlook: Emkay analysts project profitability benefits only from FY28 onwards, as customer migration (already 60% complete) nears full integration. Revenue CAGR of ~14% and PAT CAGR of ~17% are expected over FY26–29, contingent on demand-supply dynamics.

See More

Emkay Global Financial Services (EMKAY) fundamental

Emkay Global Financial Services reported a strong Q1 FY27 on a YoY basis, with total income rising 24.1% to ₹96.53 crore and PAT increasing 90.6% YoY to ₹9.11 crore. EPS also improved to ₹3.07 from ₹1.82, indicating better earnings performance, although revenue and profit were lower sequentially because financial-services earnings can fluctuate significantly between quarters. A major growth initiative is the company's expansion into wealth management. Emkay has approved the incorporation of a wholly owned subsidiary for this vertical, which could diversify revenue away from traditional broking, research and investment-banking activities. The company also incorporated Emkay Capital Pvt Ltd in August 2026, supporting its expansion into capital-market/financial-services activities. Another recent development is the approval to raise ₹50 crore through listed senior unsecured NCDs on a private-placement basis. This provides additional funding flexibility, although investors should monitor leverage and the cost of borrowing

See More

CYIENT LTD. (INVESTOR DAY HIGHLIGHTS & BROKERAGE OUTLOOK)

1. Executive Summary & Market Reaction Cyient Ltd. shares experienced a 4% jump following the company's investor day presentation, where it outlined growth and margin priorities. PDF The stock closed at ₹975.05 on Tuesday, reflecting a gain of more than 18% over the past month. 2. Strategic Roadmap & Financial Targets Growth Trajectory: The company is prioritizing near-term revenue re-acceleration, targeting double-digit year-on-year growth and steady quarter-on-quarter expansion through FY28-29. Management described FY26 as a stabilization year, with FY27 and FY28 marking a recovery phase driven by a revamped strategy. Margin Expansion: Cyient aims for near-term EBIT margins exceeding 15% and medium- to long-term margins of over 16%. The company has already improved its EBIT margin to 13.2% in Q1 FY27, up from around 12.2%, aiming to reach its 15% target through AI-led revenue leverage and operating cost efficiencies. Business Model Pivot: A newly structured go-to-market (GTM) team is shifting focus from project-based work (currently ~40% of the business) toward predictable, annuity-based contracts and larger deals. Deal Pipeline: Management confirmed the large-deal pipeline is at a record high, comprising nine qualified deals with an estimated total contract value of $300 million. 3. Institutional & Brokerage Consensus JPMorgan ('Overweight' | Target: ₹1,050): The brokerage cited the shift toward annuity-based revenue, large-deal focus, and margin expansion plans as key positives, noting that execution will be the primary catalyst for a stock re-rating. Emkay Global ('Reduce' | Target: ₹900): Emkay noted that management has addressed key growth impediments and put strategic levers in place, but awaits concrete execution before changing its rating.

See More

Honasa Consumer Shares Gain 3% After Strong Q1 Profit, Revenue Growth

Honasa Consumer shares gained more than 3% in morning trade on Friday, after the company reported a strong June-quarter performance a day earlier, with profit more than doubling and EBITDA margins expanding sharply. The company’s profit after tax rose 119% YoY in the June quarter, while revenue increased 27%. EBITDA surged 141%. Honasa reported 30.5% volume-led growth during the quarter. Its e-commerce business grew 20%, while general trade and modern trade both recorded 40% growth. Analysts said the company continues to demonstrate strong momentum, delivering growth across both revenue and margins. Emkay highlighted high-teens growth at Mamaearth, while other brands continued to expand at a rapid pace. The company had a total outlet count of around 3 lakh as of June 2026. It has also entered the fast-growing fragrance segment with the launch of its FIKN brand. They expects growth to remain robust, driven by low-double-digit growth at Mamaearth and more than 20% growth at The Derma Co. Management is targeting a high-teens revenue CAGR over the next five years, with Mamaearth expected to deliver double-digit CAGR through continued distribution expansion. Honasa implemented calibrated price increases towards the end of the first quarter to offset inflation in crude-linked raw materials and packaging costs. However, these price hikes could put some pressure on gross margins in the second quarter. The company aims to expand EBITDA margins by 100–150 basis points annually, with a long-term target of around 15%. Honasa Consumer shares have gained 74.7% so far this year.

See More

Lenskart's Profit Nearly Quadrupled. But Is the Stock Already Pricing In Too Much Growth?

reported a very strong Q1 FY27. Revenue rose 34% YoY, while PAT jumped 182% to ₹228 crore. Customer accounts and its Gold membership base also continued to grow strongly. The business clearly has momentum. But here's the more important question for investors: How much of this growth is already reflected in the stock price? That's where things get interesting. Lenskart is now valued at over ₹1 lakh crore, and even before today's results, Emkay's estimates valued the stock at around 144× FY26 earnings and 119× FY27 earnings. At that kind of valuation, simply delivering strong growth isn't enough. The company has to keep exceeding expectations. If revenue grows 30% but investors were expecting 35%, the stock can fall despite the business still growing rapidly. That's the uncomfortable part about buying high-growth companies at very high valuations. The business can execute well and the investment can still disappoint if the price already assumes years of exceptional growth. And Lenskart itself has cautioned investors not to extrapolate any single quarter's accelerated growth indefinitely, pointing instead to around 25% annual volume growth as a cleaner measure of underlying expansion. So there are really two separate questions: Is Lenskart a good business? The numbers suggest it could be. Is Lenskart a good stock at its current valuation? That's a much harder question. The takeaway. Don't confuse business quality with investment value. A great company can still be an expensive stock. At high valuations, you're not just buying today's growth. You're paying upfront for a large part of tomorrow's growth too.

See More